Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology; D000918:Antibody Specificity; D006168:Guinea Pigs; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D007152:Immunologic Capping; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000276:immunology / Q000628:therapy*; D011947:Receptors, Antigen, B-Cell / Q000276:immunology*; D013329:Structure-Activity Relationship
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007130:Immunoglobulin Idiotypes; D011947:Receptors, Antigen, B-Cell